Mangoceuticals, Inc. (NASDAQ: MGRX) is shaking up the men’s health market. The company’s $99/month all-inclusive injectable Testosterone Replacement Therapy (TRT) program, launched in mid-December, is…
February 20, 2026
November 10, 2025
Tandem Diabetes Gains FDA Approval for Mobi Pump Compatibility with Android Smartphones
Tandem Diabetes Care (NASDAQ:TNDM) announced today that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi, the world’s…
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, has announced a definitive agreement to be acquired by an affiliate of Patient Square Capital,…